| Patent No. | Patent Title: |
| 7462491 | Methods and compositions for diagnosis and monitoring of prostate... |
| 7405061 | Antigen PIPA and antibodies that bind thereto |
| 7396533 | Polypeptides and nucleic acids encoding same |
| 7396810 | Compositions and methods for treating cancer by modulating HER-2 ... |
| 7393823 | HER-2 binding antagonists |
| 7374935 | Human Rgr oncogene and truncated transcripts thereof detected in ... |
| 7371379 | Dosages for treatment with anti-ErbB2 antibodies |
| 7371813 | Method for use of IGF-binding protein for selective sensitization... |
| 7358230 | Conserved diaphanous-related formin autoregulatory domain (DAD) |
| 7341730 | Inhibitors of angiogenesis and tumor growth |
| 7276331 | Plus end-directed microtubule motor required for chromosome congr... |
| 7247703 | Immune reactivity to HER-2/neu protein for diagnosis and treatmen... |
| 7229623 | Her-2/neu fusion proteins |
| 7198920 | HER-2/neu fusion proteins |
| 7183051 | Diagnosis and treatment of cancer |
| 7175981 | Method of diagnosing stage or aggressiveness of breast and prosta... |
| 7148016 | Immunoassays to detect diseases or disease susceptibility traits |
| 7053058 | Pharmaceutical preparations and methods for inhibiting tumors |
| 7052834 | Tumor suppressor protein involved in death signaling, and diagnos... |
| 7041292 | Treating prostate cancer with anti-ErbB2 antibodies |
| 7022500 | Humanized immunoglobulins |
| 7018632 | Method for ex vivo immunization using heterologous intact bispeci... |
| 7014856 | Ganglioside-KLH conjugate vaccines plus OS-21 |
| 7009043 | Plus end-directed microtubule motor required for chromosome congr... |
| 7001601 | Ganglioside-KLH conjugate vaccine plus QS-21 |
| 6994853 | Time-staggered utilization of tumor cells in combination with int... |
| 6972180 | Method of diagnosing and monitoring malignant breast carcinomas |
| 6967022 | Ganglioside-KLH conjugate vaccines plus QS-21 |
| 6949245 | Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 ant... |
| 6946259 | Compositions and methods for treating cells having double minute ... |
| 6943235 | Transmembrane protein expressed in prostate cancer |
| 6942977 | Immunoassays for determining vitamin b12, and reagents and kits t... |
| 6936253 | Ganglioside-KLH conjugate vaccines plus QS-21 |
| 6923966 | Melanoma therapy |
| 6916476 | Ganglioslide-KLH conjugate vaccine plus QS-21 |
| 6911526 | Compounds that inhibit the interaction between signal-transducing... |
| 6844189 | Chromosome 17P-linked prostate cancer susceptibility gene |
| 6844177 | Diagnosis and treatment of PTP04 related disorders |
| 6833241 | Mammary gland chemokine |
| 6821516 | Macrophages, process for preparing the same and their use as acti... |
Quotables 
PatentStorm News
